With 1.47 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.48 million shares. The 52-week range on MRVI shows that it touched its highest point at $10.03 and its lowest point at $1.66 during that stretch. It currently has a 1-year price target of $5.20. Beta for the stock currently stands at 0.26.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MRVI was up-trending over the past week, with a rise of 6.22%, but this was up by 12.74% over a month. Three-month performance dropped to -19.26% while six-month performance fell -55.74%. The stock lost -72.53% in the past year, while it has lost -56.15% so far this year. A look at the trailing 12-month EPS for MRVI yields -1.15 with Next year EPS estimates of -0.23. For the next quarter, that number is -0.07. This implies an EPS growth rate of -182.57% for this year and 19.21% for next year. EPS is expected to decline by -26.41% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -64.27%.
Float and Shares Shorts:
At present, 143.96 million MRVI shares are outstanding with a float of 107.06 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MRVI since 7 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.06719229 being high and -$0.10079 being low. For MRVI, this leads to a yearly average estimate of -$0.078391. Based on analyst estimates, the high estimate for the next quarter is -$0.03 and the low estimate is -$0.12. The average estimate for the next quarter is thus -$0.07.
